Cargando…

Redox stress in COVID-19: Implications for hematologic disorders

COVID-19 is the respiratory illness caused by the beta coronavirus SARS-CoV-2. COVID-19 is complicated by an increased risk for adverse thrombotic events that promote organ failure and death. While the mechanism of action for SARS-CoV-2 is still being understood, how SARS-CoV-2 infection impacts the...

Descripción completa

Detalles Bibliográficos
Autor principal:	Yang, Moua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374492/ https://www.ncbi.nlm.nih.gov/pubmed/36494143 http://dx.doi.org/10.1016/j.beha.2022.101373

Ejemplares similares

Ferroptosis: Redox Imbalance and Hematological Tumorigenesis
por: Lan, Hongying, et al.
Publicado: (2022)

COVID-19 Vaccines and Autoimmune Hematologic Disorders
por: Mingot-Castellano, María Eva, et al.
Publicado: (2022)

Hematologic parameters in coronavirus infection (COVID-19) and their clinical implications
por: Waleed, Rao Muhammad, et al.
Publicado: (2020)

Hematologic disorders associated with COVID-19: a review
por: Rahi, Mandeep Singh, et al.
Publicado: (2021)

Redox Status and Hematological Variables in Melatonin-Treated Ewes during Early Pregnancy under Heat Stress
por: Bouroutzika, Efterpi V., et al.
Publicado: (2022)

Neurological Implications of COVID-19: Role of Redox Imbalance and Mitochondrial Dysfunction
por: Kaundal, Ravinder K., et al.
Publicado: (2021)

Hematologic Disorders
por: Varon, Joseph, et al.
Publicado: (2009)

Hematologic Disorders
por: Varon, Joseph
Publicado: (2016)

JS1-5 Management of hematological disorders in COVID-19 pandemic
por: Hagihara, Masao
Publicado: (2022)

Redox regulation of antioxidants, autophagy, and the response to stress: Implications for electrophile therapeutics
por: Levonen, Anna-Liisa, et al.
Publicado: (2014)

Immune landscape and redox imbalance during neurological disorders in COVID-19
por: Thakur, Abhimanyu, et al.
Publicado: (2023)

Kinase inhibitors developed for treatment of hematologic malignancies: implications for immune modulation in COVID-19
por: Jacobs, Chaja F., et al.
Publicado: (2021)

WHAT HAVE WE EXPERIENCED WITH COVID-19 IN PATIENTS WITH HEMATOLOGICAL DISORDERS?
por: ERDEM, Simge, et al.
Publicado: (2021)

The Clinical Implication of Dynamic Hematological Parameters in COVID-19: A Retrospective Study in Chongqing, China
por: Yang, Huan, et al.
Publicado: (2021)

COVID-19 in hematology: data from a hematologic and transplant unit
por: Garnica, Marcia, et al.
Publicado: (2020)

Molecular Aspects of Hematological Malignancies and Benign Hematological Disorders
por: Găman, Amelia Maria
Publicado: (2023)

COVID-19: A hematological perspective
por: Nayak, Lalitha, et al.
Publicado: (2022)

Hematological features of persons with COVID-19
por: Li, Qiubai, et al.
Publicado: (2020)

COVID-19: Review and hematologic impact
por: Letícia de Oliveira Toledo, Sílvia, et al.
Publicado: (2020)

Hematology and Immune-Related Disorders
por: Javinsky, Edward
Publicado: (2012)

Dynamic profile and clinical implications of hematological and immunological parameters in COVID-19 patients. A retrospective study
por: Suryawanshi, Shekhar Yashwant, et al.
Publicado: (2021)

Hepatic Manifestations in Hematological Disorders
por: Murakami, Jun, et al.
Publicado: (2013)

Defining the nuanced nature of redox biology in post-traumatic stress disorder
por: Reed, Emily C., et al.
Publicado: (2023)

Therapeutic Use of Convalescent Plasma in COVID-19 Infected Patients with Concomitant Hematological Disorders
por: Lanza, Francesco, et al.
Publicado: (2021)

Autoimmune Hematologic Disorders in Two Patients After mRNA COVID-19 Vaccine
por: Gaignard, Marie-Estelle, et al.
Publicado: (2021)

COVID-19 in patients with hematologic malignancy
por: Langerbeins, Petra, et al.
Publicado: (2022)

COVID-19 in Patients with Hematologic Diseases
por: Casetti, Ilaria Carola, et al.
Publicado: (2022)

Implications of COVID-19 in Neurological Disorders
por: Gaddam, Satish
Publicado: (2020)

Regulation of cytoskeletal dynamics by redox signaling and oxidative stress: implications for neuronal development and trafficking
por: Wilson, Carlos, et al.
Publicado: (2015)

Inflammation, Stress Response, and Redox Dysregulation Biomarkers: Clinical Outcomes and Pharmacological Implications for Psychosis
por: Schiavone, Stefania, et al.
Publicado: (2017)

Endothelial Activation and Stress Index (EASIX) as an Early Predictor for Mortality and Overall Survival in Hematological and Non-Hematological Patients with COVID-19: Multicenter Cohort Study
por: Kalicińska, Elżbieta, et al.
Publicado: (2021)

Is COVID-19 a New Hematologic Disease?
por: Debuc, Benjamin, et al.
Publicado: (2020)

Redox imbalance in COVID-19 pathophysiology
por: Majumder, Nairrita, et al.
Publicado: (2022)

Molecular Immunology in Hematological Disorders
por: Takami, Akiyoshi
Publicado: (2022)

Ocular Manifestations in Hematological Disorders
por: Bouazza, Mohamed, et al.
Publicado: (2022)

Extracellular Vesicles in Hematological Disorders
por: Aharon, Anat, et al.
Publicado: (2014)

Hematological disorders and pulmonary hypertension
por: Mathew, Rajamma, et al.
Publicado: (2016)

Are Hematologic Patients Trojan Horse for COVID-19?
por: Kılıçaslan, Emrah, et al.
Publicado: (2021)

Hematological changes associated with COVID‐19 infection
por: Al‐Saadi, Enass Abdul Kareem Dagher, et al.
Publicado: (2021)

Redox theory of aging: implications for health and disease
por: Go, Young-Mi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_uhesl9fab7gvb0epekln6c6kck